Tvardi Therapeutics, Inc.
TVRDBiotechnology
$0.86−2.73%As of Oct 29vs prior close
- Market cap
- $11.5M
- P/E (TTM)
- –
- From 52W high
- −82.74%
- EPS (LTM)
- $0.04
- Revenue (YE24)
- $7.1M
- Dividend yield
- 0.00%
Nomior Score
17
Distressed LaggardSpeculativeBottom 5% of the scored universe
Growth—
Quality29
Value—
Momentum3
Resilience26
Growth
+73.73%revenue a year over 8 fiscal years
YE16 $86KYE24 $7.1M
Connections
Revenue to profitQ1 YE25
The operating loss was 169% of revenue, narrower by 1220 pts on a year.
Who owns it
2funds